
    
      180 elective percutaneous coronary intervention patients with clopidogrel resistance were
      randomized to three groups, Group 1:received clopidogrel 75mg qd ;Group 2:received
      clopidogrel 150mg qd ; Group 3:received ticagrelor 90mg bid after PCI.Platelet funtion were
      tested by flowcytometric vasodilator-stimulated phosphoprotein(VASP) analysis before PCI,and
      3days,7days and 1 month after PCI,respectively.The aim of our study is to compare the
      efficacy and safety of ticagrelor with clopidogrel
    
  